Work

Seerumin ja syljen tulehdusmerkkiaineiden yhteys akuuttien ylähengitystieinfektioiden esiintyvyyteen ja palautumiseen maratonin yhteydessä

Year: 2025
Type: dissertation
Study design: Observational Study
Abstract: The aim of the study was to investigate the prevalence of upper respiratory symptoms and infections over a two-week period among marathon subjects and their matched controls. The study examined also pre-marathon risk factors that may increase the risk of infection. Among marathon runners, the relationship between serum (leukocytes, IL-1α, IL-1β, IL-4, IL-6, IL-10, IL-15, IL-23, IFN-γ, TNF-α) and saliva (COR, IgA) inflammatory markers and upper respiratory infections was investigated, as well as the impact of these markers on perceived physical and psychological recovery post-marathon. Upper respiratory tract infections (ARinf) are the most common health issue for athletes and in primary healthcare. High training loads and events like marathons can cause transient immune system disturbances, inflammation, and increase the risk of illness, particularly within 1–2 weeks after the event. Planning recovery is crucial for managing overall load and reducing illness risk. Before the marathon and half-marathon, subjects provided nasal and saliva samples and participated in blood sampling and body composition measurements. After the event, saliva and blood samples were re-collected, and body composition was measured again. Recovery and infection symptoms were monitored on days 1, 7, and 14 post-event using questionnaires, nasal samples, and symptom diaries. The experimental group consisted of men (n=17) ja women (n=19) with a regular endurance sports background (more than 250 training hours per year). The primary training modality had to be running. The control group consisted of age- and gender-matched individuals (men n=14, women n=27) who engaged in less than 250 hours of exercise per year. The results showed no statistically significant difference in infection prevalence between the experimental group (n=36) and the control group (n=41). However, a significant difference in ARinf symptoms was found between the groups (p = 0.006). Human rhinovirus was found in 89.3% of the positive nasal samples. Pre-marathon risk factors did not affect ARinf prevalence in the experimental group. In the half-marathon group, statistically significant associations were found between changes in inflammatory markers and ARinf: IL-4 (p = 0.009), IL-23 (p = 0.013), and TNF-α (p = 0.025). In the marathon group (n=10), significant associations were found between inflammatory markers (IL-1α, TNF-α, NEUT#) and recovery. In the half-marathon group (n=34), associations were found between IL-15, NEUT%, and recovery. Contrary to previous studies, no higher incidence of ARinf cases was observed among marathon participants compared to the control group. However, the experimental group experienced more ARinf symptoms, which is likely explained by the fact that endurance athletes' symptoms are often related to factors other than viral infections. Marathon participation, travel, or large crowds did not affect ARinf prevalence. It is possible that ARinf cases in the experimental group were due to an acutely impaired immune system function, particularly in the week following the marathon. The association between inflammatory markers and recovery seems to be caused by the muscle damage and soreness induced by the performance. Key words: upper respiratory tract infection, inflammatory marker, marathon, recovery
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W6996249830
Cites: 117
Cited by:
Related to: 10